IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anne Marie STOPPA, MD PhD
Hématologie, Institut Paoli Calmette, MARSEILLE
Principal Investigator - Bernard GROSBOIS, MD PhD
Médecine Interne, CHRU, Hôpital Sud, RENNES
Principal Investigator - Brigitte KOLB, MD PfD
Hématologie Clinique, Hôpital Robert Debré, CHU REIMS
Principal Investigator - Brigitte PEGOURIE, MD PhD
Hématologie, CHRU, Hôpital A.Michallon, GRENOBLE
Principal Investigator - Bruno ROYER, MD PhD
CHRU-Hôpital Sud d'Amiens-AMIENS
Principal Investigator - Catherine TRAULLE, MD PhD
Service d'Hématologie, Centre Hospitalier Lyon Sud, PIERRE BENIT
Principal Investigator - Christian BERTHOU, MD PhD
Service d'Hématologie Clinique, CHU Morvan, BREST
Principal Investigator - Cyrille HULIN, MD PhD
Hématologie, CHRU, Hôpitaux de Brabois, VANDOEUVRE
Principal Investigator - Denis CAILLOT, MD PhD
Hématologie Clinique, CHU, Hôpital d'Enfants, DIJON
Principal Investigator - Gerard MARIT, MD PhD
Hôpital Haut-Levèque de Pessac-BORDEAUX
Principal Investigator - Jean-Gabriel FUZIBET, MD PhD
Médecine Interne, Oncologie, Hôpital de l'Archet 1, NICE
Principal Investigator - Jean-Paul FERMAND, MD PhD
Service Immuno-Hématologie, Hôpital Saint-Louis, PARIS
Principal Investigator - Laurent GARDERET, MD PhD
Maladies du Sang, CHU - Hôpital St Antoine, PARIS
Principal Investigator - Lofti BENBOUBKER, MD PhD
Onco-Hématologie, CHRU- Hôpital Bretonneau, TOURS
Principal Investigator - Margaret MACRO, MD PhD
Hématologie, CHU, CAEN
Principal Investigator - Michel ATTAL, MD PhD
Hématologie, CHRU, Hôpital Purpan, TOULOUSE
Principal Investigator - Philippe MOREAU, MD PhD
Maladies du Sang, CHRU, Hôtel Dieu, NANTES
Principal InvestigatorKOL profile → - Philippe RODON, MD PhD
Centre Hospitalier de Blois -BLOIS
Principal Investigator - Sabine BRECHIGNAC, MD PhD
Hôpital Avicenne-Bobigny- PARIS
Principal Investigator - Xavier Leleu, MD PhD
Service des maladies du sang, CHRU de Lille
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chru-Hôpital Sud, Avenue Laennec,
Amiens, France
- Hématologie, Hôpital Avicenne
Bobigny, France
- Hématologie, Chu, Avenue G.Clemenceau
Caen, France
- Hématologie Clinique, Chu, Hôpital D'Enfants
Dijon, France
- Hématologie, Chru, Hôpital A.Michallon
Grenoble, France
- Service Des Maladies Du Sang, Chru
Lille, France
- Hôpital Edouard Herriot
Lyon, France
- Hématologie, Institut Paoli Calmette
Marseille, France
- Hématologie, Chru, Hôpitaux de Brabois
Nancy, France
- Maladies Du Sang, Chru, Hôtel Dieu
Nantes, France
- Maladies Du Sang, Chu - Hôpital St Antoine
Paris, France
- Service Immuno-Hématologie, Hôpital Saint-Louis
Paris, France
- Service Des Maladies Du Sang, Hôpital Haut-Levèque
Pessac, France
- Service D'Hématologie, Centre Hospitalier Lyon Sud
Pierre-Bénite, France
- Hématologie Clinique, Hôpital Robert Debré, Chu Reims
Reims, France
- Hôpital Pontchaillou, Chu de Rennes
Rennes, France
- Médecine Interne, Chru, Hôpital Sud
Rennes, France
- Hématologie, Chru, Hôpital Purpan
Toulouse, France
- Onco-Hématologie, Chru- Hôpital Bretonneau
Tours, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2009
- Primary completion
- 30 Apr 2014
- Completion
- 30 Apr 2015
- Last update posted
- 14 May 2026
- Registered enrollment
- 84
- Registry id
- NCT01053949
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.